iHuman Inc.
Operating within the People's Republic of China, iHuman Inc. specializes in delivering educational resources aimed at fostering cognitive growth. Their offerings reach a broad audience, encompassing individual consumers, early learning institutions, and wholesale distributors. A significant portion of their portfolio…
1D
+0.9%
1W
+0.0%
1M
-1.7%
6M
-32.7%
YTD
-45.2%
1Y
-59.9%
2Y
-39.8%
5Y
-77.2%
10Y
–
Next earnings date
17/12/2026 (in 61 days)
Volatility around earnings
~5% weaker price swings than usual
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 23/12/2020
P/E
3.29
P/B
0.09
EV/EBITDA
-79.02
RETURN ON EQUITY
-2.1%
NET MARGIN
-10.1%
DEBT/EQUITY
0.01
DIVIDEND YIELD
7.4%
AS OF
30/06/2026
FREE FLOAT
98.9%
FLOAT SHARES
10,174,580
AVG. DAILY VOLUME (30D)
4,939
iHuman Inc. is a company in the Consumer Defensive sector, Education & Training Services industry, headquartered in China.
The CEO is Peng Dai, the company employs around 558 people.
The IPO was on 09/10/2020; the stock trades on NYSE under the ticker IH.
1 analysts rate the stock, the consensus is Buy (as of 23/12/2020).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 17/12/2026.
Around past earnings, price swings were roughly -5% stronger than usual.
Yes. The last dividend was US$0.10 per share, ex-date 17/04/2026, paid on 15/05/2026.
The dividend yield is 7.4% (as of 30/06/2026).
Comparable stocks include TAL Education Group, Afya, Yatsen Holding, Walmart, Costco Wholesale, Coca-Cola Company, Procter & Gamble Company and Philip Morris International.
Clicking "Analyze stock" lets five strategies assess iHuman against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.